Fintech▲ 50

MiNK Therapeutics Announces Abstract Acceptance

Globenewswire·April 1, 2026 at 11:30 AM

MiNK Therapeutics, Inc. has announced that an abstract has been accepted for presentation at the American Thoracic Society (ATS) 2020 International Conference. The presentation will likely focus on the company's clinical-stage biopharmaceutical research. This acceptance highlights the company's ongoing contributions to scientific discourse and its progress in developing novel therapies within its research areas.

Tickers

$INKT

MiNK Therapeutics Announces Abstract Acceptance

Companies Balance AI Opportunities With Fear of Bubble

Sona Secures $45 Million for AI Platform Expansion

Tariffs Reshape Business Strategy One Year Later

eToro launches crypto trading in New York